3D Pharmacophore models are three-dimensional ensembles of chemically specified interactions of a ligand in its bioactive state. They are now an important technique in drug design because they offer a sophisticated method of deciphering chemically stored ligand information. The important research for using 3D pharmacophore models in high - throughput screening and mechanistic investigations for protein functioning are summarised in this review, along with an outline of the method's fundamental principles. We also go over current advancements in the area. Since these methods take into account macromolecule-ligand interactions as dynamic and hence display an interaction pattern that is physiologically accurate, combining 3D pharmacophore models with molecular dynamics simulations might be a huge step forward. The effective use of 3D pharmacophore data in artificial intelligence and machine learning is another trend. Other themes include using 3D pharmacophore data effectively in machine learning and artificial intelligence applications or providing 3D pharmacophore modelling on publicly available web servers. Recent advancements demonstrate that 3D pharmacophore modelling is a dynamic area with many implications in drug discovery and beyond.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia